Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis

Background: Currently, myelin oligodendrocyte glycoprotein (MOG)-IgG-associated encephalomyelitis (MOG-EM) is regarded as an independent inflammatory demyelinating disease. Magnetic resonance imaging (MRI) abnormalities occur in 44.4% of patients with MOG-EM. However, symmetrical deep gray matter in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC neurology 2021-01, Vol.21 (1), p.10-10, Article 10
Hauptverfasser: Shen, Weibing, Zhang, Yaner, Zhou, Chenguang, Shen, Yaoyao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue 1
container_start_page 10
container_title BMC neurology
container_volume 21
creator Shen, Weibing
Zhang, Yaner
Zhou, Chenguang
Shen, Yaoyao
description Background: Currently, myelin oligodendrocyte glycoprotein (MOG)-IgG-associated encephalomyelitis (MOG-EM) is regarded as an independent inflammatory demyelinating disease. Magnetic resonance imaging (MRI) abnormalities occur in 44.4% of patients with MOG-EM. However, symmetrical deep gray matter involvement with leptomeningeal enhancement is rarely described in the literature. Case presentation: A 3-year-old boy was admitted to our hospital because of acute onset fever, headache, vomiting and disturbance of consciousness. Neurological examination showed somnolence, neck stiffness and positive Kernig's sign. Brain MRI demonstrated bilateral symmetrical lesions in the basal ganglia and thalamus as well as diffuse leptomeningeal enhancement along the sulci of bilateral hemisphere. Cerebrospinal fluid analysis demonstrated increased cell count (7 cells/mm3, mononuclear cells dominant) and protein (1.17 g/L) without glucose and chloride abnormality. Work-up for infectious and autoimmune causes, serum MOG IgG was positive by cell based assay. Therefore, a diagnosis of MOG-EM was established according to the international recommendatory criteria in 2018. He was administrated with intravenous methylprednisolone followed by oral corticosteroids and had recovered completely within 1 week. Conclusions: In the setting of meningoencephalitis-like clinical presentation with bilateral symmetrical deep gray matter involvement, MOG-EM should be distinguished from other infectious and autoimmune disorders, such as Epstein-Barr virus (EBV) encephalitis, Japanese encephalitis and Anti-NMDA receptor (NMDAR) encephalitis. Besides, aseptic meningitis associated with leptomeningeal enhancement may be an atypical phenotype of MOG-EM.
doi_str_mv 10.1186/s12883-020-02041-3
format Article
fullrecord <record><control><sourceid>gale_webof</sourceid><recordid>TN_cdi_webofscience_primary_000608175400001CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A650600462</galeid><doaj_id>oai_doaj_org_article_1bbe69f5d31d4ca8a23117bb9712be84</doaj_id><sourcerecordid>A650600462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-37f1f85c5d2e80c6da64c7dd8d923623297d349f1ac80cc2b01341268f3acb8b3</originalsourceid><addsrcrecordid>eNqNUk1vEzEQXSEQLYE_wAGtxAUJbfHX2t4LUhtBiFTUC5wtr-1NHO3aYe2kyh_gdzPpltAiDsiyPPa890YzfkXxGqMLjCX_kDCRklaIoONmuKJPinPMBK4IFeLpg_iseJHSBiEsJMPPizNKGW4YZufFzyvf6-xG3ZfpMAwuj95AbJ3blqtRH8pBZ0iXPuxjv3eDC7nUwZa92-YINx9WDvAurHUwU9qHUpdm7Xtb3vq8Lr_eLKrlalHplKLxUMwC3LjtWvdxOLjeZ59eFs863Sf36v6cFd8_f_o2_1Jd3yyW88vrytSc5oqKDneyNrUlTiLDrebMCGulbQjlhJJGWMqaDmsDaUNahKFTwmVHtWllS2fFctK1UW_UdvSDHg8qaq_uHuK4UnrM3vRO4bZ1vOlqS7FlRktNKMaibRuBSeskA62Pk9Z21w7OGugdxvhI9HEm-LVaxb0SooGPkCDw7l5gjD92LmU1-GRc3-vg4i4pwgSvOZY1Aujbv6CbuBsDjOqIkpJQydkf1EpDAz50Eeqao6i65DXiCDEY0qy4-AcKlnWDNzG4zsP7IwKZCGaMKY2uO_WIkTo6UU1OVOBCdedERYH05uF0TpTf1gOAnAC3ro1dMv5oihMMIagusagZRAjPfdbZxzCPu5CB-v7_qfQXToT7BA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478823864</pqid></control><display><type>article</type><title>Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Shen, Weibing ; Zhang, Yaner ; Zhou, Chenguang ; Shen, Yaoyao</creator><creatorcontrib>Shen, Weibing ; Zhang, Yaner ; Zhou, Chenguang ; Shen, Yaoyao</creatorcontrib><description>Background: Currently, myelin oligodendrocyte glycoprotein (MOG)-IgG-associated encephalomyelitis (MOG-EM) is regarded as an independent inflammatory demyelinating disease. Magnetic resonance imaging (MRI) abnormalities occur in 44.4% of patients with MOG-EM. However, symmetrical deep gray matter involvement with leptomeningeal enhancement is rarely described in the literature. Case presentation: A 3-year-old boy was admitted to our hospital because of acute onset fever, headache, vomiting and disturbance of consciousness. Neurological examination showed somnolence, neck stiffness and positive Kernig's sign. Brain MRI demonstrated bilateral symmetrical lesions in the basal ganglia and thalamus as well as diffuse leptomeningeal enhancement along the sulci of bilateral hemisphere. Cerebrospinal fluid analysis demonstrated increased cell count (7 cells/mm3, mononuclear cells dominant) and protein (1.17 g/L) without glucose and chloride abnormality. Work-up for infectious and autoimmune causes, serum MOG IgG was positive by cell based assay. Therefore, a diagnosis of MOG-EM was established according to the international recommendatory criteria in 2018. He was administrated with intravenous methylprednisolone followed by oral corticosteroids and had recovered completely within 1 week. Conclusions: In the setting of meningoencephalitis-like clinical presentation with bilateral symmetrical deep gray matter involvement, MOG-EM should be distinguished from other infectious and autoimmune disorders, such as Epstein-Barr virus (EBV) encephalitis, Japanese encephalitis and Anti-NMDA receptor (NMDAR) encephalitis. Besides, aseptic meningitis associated with leptomeningeal enhancement may be an atypical phenotype of MOG-EM.</description><identifier>ISSN: 1471-2377</identifier><identifier>EISSN: 1471-2377</identifier><identifier>DOI: 10.1186/s12883-020-02041-3</identifier><identifier>PMID: 33419414</identifier><language>eng</language><publisher>LONDON: Springer Nature</publisher><subject>Acids ; Antibodies ; Aseptic meningitis ; Autoimmune diseases ; Basal ganglia ; Case Report ; Case studies ; Cerebrospinal fluid ; Child, Preschool ; Clinical Neurology ; Consciousness ; Corticosteroids ; Deep gray matter ; Demyelinating Autoimmune Diseases, CNS - pathology ; Demyelinating diseases ; Demyelination ; Diagnosis ; Disease ; Encephalitis ; Encephalomyelitis ; Encephalomyelitis - immunology ; Encephalomyelitis - pathology ; Epidemics ; Epstein-Barr virus ; Fever ; Glutamic acid receptors ; Glutamic acid receptors (ionotropic) ; Glycoproteins ; Gray Matter - pathology ; Headaches ; Health aspects ; HIV ; Human immunodeficiency virus ; Humans ; Immunoglobulin G ; Immunoglobulin G - immunology ; Intravenous administration ; Laboratories ; Leptomeningeal enhancement ; Leukocytes (mononuclear) ; Life Sciences &amp; Biomedicine ; Magnetic Resonance Imaging ; Male ; Meninges ; Meninges - pathology ; Meningitis ; Meningoencephalitis ; Methylprednisolone ; Mosquitoes ; Multiple sclerosis ; Myelin ; Myelin oligodendrocyte glycoprotein ; Myelin-Oligodendrocyte Glycoprotein - immunology ; Neuroimaging ; Neurosciences &amp; Neurology ; Patients ; Pediatric research ; Phenotypes ; Proteins ; Science &amp; Technology ; Substantia grisea ; Vomiting</subject><ispartof>BMC neurology, 2021-01, Vol.21 (1), p.10-10, Article 10</ispartof><rights>COPYRIGHT 2021 BioMed Central Ltd.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>6</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000608175400001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c563t-37f1f85c5d2e80c6da64c7dd8d923623297d349f1ac80cc2b01341268f3acb8b3</citedby><cites>FETCH-LOGICAL-c563t-37f1f85c5d2e80c6da64c7dd8d923623297d349f1ac80cc2b01341268f3acb8b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791788/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791788/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,39263,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33419414$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Weibing</creatorcontrib><creatorcontrib>Zhang, Yaner</creatorcontrib><creatorcontrib>Zhou, Chenguang</creatorcontrib><creatorcontrib>Shen, Yaoyao</creatorcontrib><title>Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis</title><title>BMC neurology</title><addtitle>BMC NEUROL</addtitle><addtitle>BMC Neurol</addtitle><description>Background: Currently, myelin oligodendrocyte glycoprotein (MOG)-IgG-associated encephalomyelitis (MOG-EM) is regarded as an independent inflammatory demyelinating disease. Magnetic resonance imaging (MRI) abnormalities occur in 44.4% of patients with MOG-EM. However, symmetrical deep gray matter involvement with leptomeningeal enhancement is rarely described in the literature. Case presentation: A 3-year-old boy was admitted to our hospital because of acute onset fever, headache, vomiting and disturbance of consciousness. Neurological examination showed somnolence, neck stiffness and positive Kernig's sign. Brain MRI demonstrated bilateral symmetrical lesions in the basal ganglia and thalamus as well as diffuse leptomeningeal enhancement along the sulci of bilateral hemisphere. Cerebrospinal fluid analysis demonstrated increased cell count (7 cells/mm3, mononuclear cells dominant) and protein (1.17 g/L) without glucose and chloride abnormality. Work-up for infectious and autoimmune causes, serum MOG IgG was positive by cell based assay. Therefore, a diagnosis of MOG-EM was established according to the international recommendatory criteria in 2018. He was administrated with intravenous methylprednisolone followed by oral corticosteroids and had recovered completely within 1 week. Conclusions: In the setting of meningoencephalitis-like clinical presentation with bilateral symmetrical deep gray matter involvement, MOG-EM should be distinguished from other infectious and autoimmune disorders, such as Epstein-Barr virus (EBV) encephalitis, Japanese encephalitis and Anti-NMDA receptor (NMDAR) encephalitis. Besides, aseptic meningitis associated with leptomeningeal enhancement may be an atypical phenotype of MOG-EM.</description><subject>Acids</subject><subject>Antibodies</subject><subject>Aseptic meningitis</subject><subject>Autoimmune diseases</subject><subject>Basal ganglia</subject><subject>Case Report</subject><subject>Case studies</subject><subject>Cerebrospinal fluid</subject><subject>Child, Preschool</subject><subject>Clinical Neurology</subject><subject>Consciousness</subject><subject>Corticosteroids</subject><subject>Deep gray matter</subject><subject>Demyelinating Autoimmune Diseases, CNS - pathology</subject><subject>Demyelinating diseases</subject><subject>Demyelination</subject><subject>Diagnosis</subject><subject>Disease</subject><subject>Encephalitis</subject><subject>Encephalomyelitis</subject><subject>Encephalomyelitis - immunology</subject><subject>Encephalomyelitis - pathology</subject><subject>Epidemics</subject><subject>Epstein-Barr virus</subject><subject>Fever</subject><subject>Glutamic acid receptors</subject><subject>Glutamic acid receptors (ionotropic)</subject><subject>Glycoproteins</subject><subject>Gray Matter - pathology</subject><subject>Headaches</subject><subject>Health aspects</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin G - immunology</subject><subject>Intravenous administration</subject><subject>Laboratories</subject><subject>Leptomeningeal enhancement</subject><subject>Leukocytes (mononuclear)</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Meninges</subject><subject>Meninges - pathology</subject><subject>Meningitis</subject><subject>Meningoencephalitis</subject><subject>Methylprednisolone</subject><subject>Mosquitoes</subject><subject>Multiple sclerosis</subject><subject>Myelin</subject><subject>Myelin oligodendrocyte glycoprotein</subject><subject>Myelin-Oligodendrocyte Glycoprotein - immunology</subject><subject>Neuroimaging</subject><subject>Neurosciences &amp; Neurology</subject><subject>Patients</subject><subject>Pediatric research</subject><subject>Phenotypes</subject><subject>Proteins</subject><subject>Science &amp; Technology</subject><subject>Substantia grisea</subject><subject>Vomiting</subject><issn>1471-2377</issn><issn>1471-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNqNUk1vEzEQXSEQLYE_wAGtxAUJbfHX2t4LUhtBiFTUC5wtr-1NHO3aYe2kyh_gdzPpltAiDsiyPPa890YzfkXxGqMLjCX_kDCRklaIoONmuKJPinPMBK4IFeLpg_iseJHSBiEsJMPPizNKGW4YZufFzyvf6-xG3ZfpMAwuj95AbJ3blqtRH8pBZ0iXPuxjv3eDC7nUwZa92-YINx9WDvAurHUwU9qHUpdm7Xtb3vq8Lr_eLKrlalHplKLxUMwC3LjtWvdxOLjeZ59eFs863Sf36v6cFd8_f_o2_1Jd3yyW88vrytSc5oqKDneyNrUlTiLDrebMCGulbQjlhJJGWMqaDmsDaUNahKFTwmVHtWllS2fFctK1UW_UdvSDHg8qaq_uHuK4UnrM3vRO4bZ1vOlqS7FlRktNKMaibRuBSeskA62Pk9Z21w7OGugdxvhI9HEm-LVaxb0SooGPkCDw7l5gjD92LmU1-GRc3-vg4i4pwgSvOZY1Aujbv6CbuBsDjOqIkpJQydkf1EpDAz50Eeqao6i65DXiCDEY0qy4-AcKlnWDNzG4zsP7IwKZCGaMKY2uO_WIkTo6UU1OVOBCdedERYH05uF0TpTf1gOAnAC3ro1dMv5oihMMIagusagZRAjPfdbZxzCPu5CB-v7_qfQXToT7BA</recordid><startdate>20210108</startdate><enddate>20210108</enddate><creator>Shen, Weibing</creator><creator>Zhang, Yaner</creator><creator>Zhou, Chenguang</creator><creator>Shen, Yaoyao</creator><general>Springer Nature</general><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210108</creationdate><title>Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis</title><author>Shen, Weibing ; Zhang, Yaner ; Zhou, Chenguang ; Shen, Yaoyao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-37f1f85c5d2e80c6da64c7dd8d923623297d349f1ac80cc2b01341268f3acb8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Antibodies</topic><topic>Aseptic meningitis</topic><topic>Autoimmune diseases</topic><topic>Basal ganglia</topic><topic>Case Report</topic><topic>Case studies</topic><topic>Cerebrospinal fluid</topic><topic>Child, Preschool</topic><topic>Clinical Neurology</topic><topic>Consciousness</topic><topic>Corticosteroids</topic><topic>Deep gray matter</topic><topic>Demyelinating Autoimmune Diseases, CNS - pathology</topic><topic>Demyelinating diseases</topic><topic>Demyelination</topic><topic>Diagnosis</topic><topic>Disease</topic><topic>Encephalitis</topic><topic>Encephalomyelitis</topic><topic>Encephalomyelitis - immunology</topic><topic>Encephalomyelitis - pathology</topic><topic>Epidemics</topic><topic>Epstein-Barr virus</topic><topic>Fever</topic><topic>Glutamic acid receptors</topic><topic>Glutamic acid receptors (ionotropic)</topic><topic>Glycoproteins</topic><topic>Gray Matter - pathology</topic><topic>Headaches</topic><topic>Health aspects</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin G - immunology</topic><topic>Intravenous administration</topic><topic>Laboratories</topic><topic>Leptomeningeal enhancement</topic><topic>Leukocytes (mononuclear)</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Meninges</topic><topic>Meninges - pathology</topic><topic>Meningitis</topic><topic>Meningoencephalitis</topic><topic>Methylprednisolone</topic><topic>Mosquitoes</topic><topic>Multiple sclerosis</topic><topic>Myelin</topic><topic>Myelin oligodendrocyte glycoprotein</topic><topic>Myelin-Oligodendrocyte Glycoprotein - immunology</topic><topic>Neuroimaging</topic><topic>Neurosciences &amp; Neurology</topic><topic>Patients</topic><topic>Pediatric research</topic><topic>Phenotypes</topic><topic>Proteins</topic><topic>Science &amp; Technology</topic><topic>Substantia grisea</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shen, Weibing</creatorcontrib><creatorcontrib>Zhang, Yaner</creatorcontrib><creatorcontrib>Zhou, Chenguang</creatorcontrib><creatorcontrib>Shen, Yaoyao</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Weibing</au><au>Zhang, Yaner</au><au>Zhou, Chenguang</au><au>Shen, Yaoyao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis</atitle><jtitle>BMC neurology</jtitle><stitle>BMC NEUROL</stitle><addtitle>BMC Neurol</addtitle><date>2021-01-08</date><risdate>2021</risdate><volume>21</volume><issue>1</issue><spage>10</spage><epage>10</epage><pages>10-10</pages><artnum>10</artnum><issn>1471-2377</issn><eissn>1471-2377</eissn><abstract>Background: Currently, myelin oligodendrocyte glycoprotein (MOG)-IgG-associated encephalomyelitis (MOG-EM) is regarded as an independent inflammatory demyelinating disease. Magnetic resonance imaging (MRI) abnormalities occur in 44.4% of patients with MOG-EM. However, symmetrical deep gray matter involvement with leptomeningeal enhancement is rarely described in the literature. Case presentation: A 3-year-old boy was admitted to our hospital because of acute onset fever, headache, vomiting and disturbance of consciousness. Neurological examination showed somnolence, neck stiffness and positive Kernig's sign. Brain MRI demonstrated bilateral symmetrical lesions in the basal ganglia and thalamus as well as diffuse leptomeningeal enhancement along the sulci of bilateral hemisphere. Cerebrospinal fluid analysis demonstrated increased cell count (7 cells/mm3, mononuclear cells dominant) and protein (1.17 g/L) without glucose and chloride abnormality. Work-up for infectious and autoimmune causes, serum MOG IgG was positive by cell based assay. Therefore, a diagnosis of MOG-EM was established according to the international recommendatory criteria in 2018. He was administrated with intravenous methylprednisolone followed by oral corticosteroids and had recovered completely within 1 week. Conclusions: In the setting of meningoencephalitis-like clinical presentation with bilateral symmetrical deep gray matter involvement, MOG-EM should be distinguished from other infectious and autoimmune disorders, such as Epstein-Barr virus (EBV) encephalitis, Japanese encephalitis and Anti-NMDA receptor (NMDAR) encephalitis. Besides, aseptic meningitis associated with leptomeningeal enhancement may be an atypical phenotype of MOG-EM.</abstract><cop>LONDON</cop><pub>Springer Nature</pub><pmid>33419414</pmid><doi>10.1186/s12883-020-02041-3</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2377
ispartof BMC neurology, 2021-01, Vol.21 (1), p.10-10, Article 10
issn 1471-2377
1471-2377
language eng
recordid cdi_webofscience_primary_000608175400001CitationCount
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central; Springer Nature OA/Free Journals
subjects Acids
Antibodies
Aseptic meningitis
Autoimmune diseases
Basal ganglia
Case Report
Case studies
Cerebrospinal fluid
Child, Preschool
Clinical Neurology
Consciousness
Corticosteroids
Deep gray matter
Demyelinating Autoimmune Diseases, CNS - pathology
Demyelinating diseases
Demyelination
Diagnosis
Disease
Encephalitis
Encephalomyelitis
Encephalomyelitis - immunology
Encephalomyelitis - pathology
Epidemics
Epstein-Barr virus
Fever
Glutamic acid receptors
Glutamic acid receptors (ionotropic)
Glycoproteins
Gray Matter - pathology
Headaches
Health aspects
HIV
Human immunodeficiency virus
Humans
Immunoglobulin G
Immunoglobulin G - immunology
Intravenous administration
Laboratories
Leptomeningeal enhancement
Leukocytes (mononuclear)
Life Sciences & Biomedicine
Magnetic Resonance Imaging
Male
Meninges
Meninges - pathology
Meningitis
Meningoencephalitis
Methylprednisolone
Mosquitoes
Multiple sclerosis
Myelin
Myelin oligodendrocyte glycoprotein
Myelin-Oligodendrocyte Glycoprotein - immunology
Neuroimaging
Neurosciences & Neurology
Patients
Pediatric research
Phenotypes
Proteins
Science & Technology
Substantia grisea
Vomiting
title Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T18%3A30%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bilateral%20symmetrical%20deep%20gray%20matter%20involvement%20and%20leptomeningeal%20enhancement%20in%20a%20child%20with%20MOG-IgG-associated%20encephalomyelitis&rft.jtitle=BMC%20neurology&rft.au=Shen,%20Weibing&rft.date=2021-01-08&rft.volume=21&rft.issue=1&rft.spage=10&rft.epage=10&rft.pages=10-10&rft.artnum=10&rft.issn=1471-2377&rft.eissn=1471-2377&rft_id=info:doi/10.1186/s12883-020-02041-3&rft_dat=%3Cgale_webof%3EA650600462%3C/gale_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478823864&rft_id=info:pmid/33419414&rft_galeid=A650600462&rft_doaj_id=oai_doaj_org_article_1bbe69f5d31d4ca8a23117bb9712be84&rfr_iscdi=true